Lymphangioma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 7: Line 7:
* Lymphangioma is a common benign tumor that often grows proportionally to the patients’ body growth rate.  
* Lymphangioma is a common benign tumor that often grows proportionally to the patients’ body growth rate.  
* The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is the result of is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels.
* The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is the result of is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels.
 
* The progression to lymphangioma usually involves the following growth factors:
:* VEGF-C
:* VEGFR-3
:* Prox-1
:* bFGF
:* PEDF
:* Thrombospondin
:* Reelin
:* cMAF
:* Integrin-α1, -α9
==Genetics==
==Genetics==
==Associated Conditions==
==Associated Conditions==

Revision as of 15:32, 10 February 2016

Lymphangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphangioma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangioma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangioma pathophysiology

CDC on Lymphangioma pathophysiology

Lymphangioma pathophysiology in the news

Blogs on Lymphangioma pathophysiology

Directions to Hospitals Treating Lymphangioma

Risk calculators and risk factors for Lymphangioma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

Pathogenesis

  • Lymphangioma arises from lymphatic vessels, which are a vital part of the circulatory and immune system, where they are normally involved in re-circulation of excess body fluid back into the blood stream.
  • Lymphangioma is a common benign tumor that often grows proportionally to the patients’ body growth rate.
  • The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is the result of is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels.
  • The progression to lymphangioma usually involves the following growth factors:
  • VEGF-C
  • VEGFR-3
  • Prox-1
  • bFGF
  • PEDF
  • Thrombospondin
  • Reelin
  • cMAF
  • Integrin-α1, -α9

Genetics

Associated Conditions

Gross Pathology

Microscopic Pathology

Gallery

References


Template:WikiDoc Sources